7:01 AM
Mar 25, 2019
 |  BC Extra  |  Company News

Thermo Fisher buying gene therapy manufacturer Brammer Bio

Thermo Fisher will pay $1.7 billion to acquire gene and cell therapy contract development and manufacturing company Brammer Bio, giving it vector manufacturing sites in Massachusetts and Florida.

Thermo Fisher Scientific Inc. (NYSE:TMO), which chiefly makes laboratory instruments and equipment, said Brammer Bio (Cambridge, Mass.) is likely to generate $250 million in 2019 revenue.

Read the full 250 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >